Azenta (AZTA) Non-Current Deferred Tax Liability (2013 - 2026)
Azenta (AZTA) recorded quarterly Non-Current Deferred Tax Liability of $15.7 million in Q1 2026, up 3.27% quarter-over-quarter from $15.2 million in Q4 2025, and down 29.43% on a YoY basis from $22.3 million in Q1 2025.
Azenta (AZTA) Non-Current Deferred Tax Liability (2013 - 2026) Analysis & Trends
Azenta's Non-Current Deferred Tax Liability history runs 14 years deep, the most recent figure standing at $15.7 million for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability fell 29.43% year-over-year to $15.7 million; the TTM figure through Mar 2026 stood at $15.7 million (down 29.43% YoY), while the FY2025 annual figure was $15.2 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability was $15.7 million for Q1 2026 at Azenta, up from $15.2 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $85.9 million in Q4 2022 to a low of $15.2 million in Q4 2025.
- Historically, Non-Current Deferred Tax Liability has averaged $43.0 million across 5 years, with a median of $44.3 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Non-Current Deferred Tax Liability surged 553.57% in 2022, then tumbled 72.98% in 2024.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $85.9 million in 2022, then dropped by 23.31% to $65.9 million in 2023, then slumped by 71.2% to $19.0 million in 2024, then declined by 19.62% to $15.2 million in 2025, then increased by 3.27% to $15.7 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $15.7 million (Q1 2026), $15.2 million (Q4 2025), and $18.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Azenta | 1.06 Bn | 682.62 Mn | 62.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.75 Mn |
| Mar 31, 2026 | 15.75 Mn |
| Dec 31, 2025 | 15.25 Mn |
| Dec 31, 2025 | 15.25 Mn |
| Sep 30, 2025 | 18.25 Mn |
| Sep 30, 2025 | 18.25 Mn |
| Jun 30, 2025 | 20.32 Mn |
| Jun 30, 2025 | 20.32 Mn |
| Mar 31, 2025 | 22.31 Mn |
| Mar 31, 2025 | 22.31 Mn |
| Dec 31, 2024 | 18.97 Mn |
| Dec 31, 2024 | 18.97 Mn |
| Sep 30, 2024 | 18.18 Mn |
| Sep 30, 2024 | 18.18 Mn |
| Jun 30, 2024 | 58.08 Mn |
| Jun 30, 2024 | 58.08 Mn |
| Mar 31, 2024 | 62.27 Mn |
| Mar 31, 2024 | 62.27 Mn |
| Dec 31, 2023 | 65.87 Mn |
| Dec 31, 2023 | 65.87 Mn |